Low Mean Nocturnal Baseline Impedance is Associated With a Pathological Acid Exposure Time in Children

Yolainis Rosado-Arias1, Erick Manuel Toro-Monjaraz, Roberto Cervantes-Bustamante

  • 1Departement of Gastroenterology and Nutrition Department, at Instituto Nacional de Pediatria, Mexico, Mexico.

Insights

Children with pathological acid exposure time (AET) have lower baseline impedance (BI) and mean nocturnal baseline impedance (MNBI) values. These impedance measurements are valuable for assessing mucosal integrity in pediatric GERD evaluations.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Physiology
  • Diagnostic Medicine

Background:

  • Baseline impedance (BI) and mean nocturnal baseline impedance (MNBI) are indicators of mucosal integrity.
  • Pathologic acid exposure time (AET) is a key factor in gastroesophageal reflux disease (GERD).
  • Understanding the relationship between impedance measures and AET in children is crucial for accurate diagnosis.

Purpose of the Study:

  • To investigate the association between BI and MNBI with AET in pediatric patients.
  • To determine if impedance measurements can serve as reliable markers for mucosal integrity in children with suspected GERD.

Main Methods:

  • A retrospective study of children (≤18 years) undergoing endoscopy and pH-impedance monitoring (pH-MII).
  • Esophagitis grading using the Los Angeles classification.
  • Pathological AET defined by age-specific thresholds (≥5% for >1 year, ≥10% for ≤1 year).
  • BI and MNBI measurements were taken and averaged for analysis.

Main Results:

  • 25% of the 68 included patients had pathological AET.
  • MNBI was significantly higher than BI in channels 5 and 6.
  • Lower BI and MNBI values were observed in patients with pathological AET compared to those with normal AET.

Conclusions:

  • Children with pathological AET exhibit lower impedance values.
  • BI and MNBI measurements are recommended for routine pH-MII assessments in pediatric GERD evaluations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
1.4K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
648
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
33
Respiratory Regulation of Acid-Base Balance01:18

Respiratory Regulation of Acid-Base Balance

Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2​​ and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
831
Acid-Base Balance01:25

Acid-Base Balance

The human body maintains a narrow pH range regulated through acid-base balance. This balance is crucial as changes in the hydrogen ion concentration can disrupt cell membrane stability, alter protein structures, and change enzyme activities. The normal pH of arterial blood is 7.4, venous blood and interstitial fluid is 7.35, and intracellular fluid averages 7.0.
When the pH of arterial blood rises above 7.45, it results in a condition called alkalosis. Conversely, a drop below 7.35 leads to...
1.7K